Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies
The severe acute respiratory syndrome coronavirus 2 Omicron BA. 1 sublineage has been
supplanted in many countries by the BA. 2 sublineage. BA. 2 differs from BA. 1 by about 21 …
supplanted in many countries by the BA. 2 sublineage. BA. 2 differs from BA. 1 by about 21 …
Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
S Chen, Z Huang, Y Guo, H Guo, L Jian, J Xiao, X Yao… - Cell Discovery, 2023 - nature.com
Dear Editor, SARS-CoV-2 inevitably evolves toward being more robust at multiplying. In the
herd immunity era, mutations allowing SARS-CoV-2 to bypass the immunity acquired from …
herd immunity era, mutations allowing SARS-CoV-2 to bypass the immunity acquired from …
Evolution and neutralization escape of the SARS-CoV-2 BA. 2.86 subvariant
Abstract Omicron BA. 2.86 subvariant differs from Omicron BA. 2 as well as recently
circulating variants by over 30 mutations in the spike protein alone. Here we report on the …
circulating variants by over 30 mutations in the spike protein alone. Here we report on the …
Augmented neutralisation resistance of emerging omicron subvariants BA. 2.12. 1, BA. 4, and BA. 5
P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet Infectious …, 2022 - thelancet.com
1 Arora P, Zhang L, Krüger N, et al. SARS-CoV-2 omicron sublineages show comparable
cell entry but differential neutralization by therapeutic antibodies. Cell Host Microbe 2022; …
cell entry but differential neutralization by therapeutic antibodies. Cell Host Microbe 2022; …
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
Highly transmissible Omicron variants of SARS-CoV-2 currently dominate globally. Here, we
compare neutralization of Omicron BA. 1, BA. 1.1, and BA. 2. BA. 2 RBD has slightly higher …
compare neutralization of Omicron BA. 1, BA. 1.1, and BA. 2. BA. 2 RBD has slightly higher …
Resistance of SARS-CoV-2 omicron subvariant BA. 4.6 to antibody neutralisation
SARS-CoV-2, the causative agent of the COVID-19 pandemic, continues to evolve. A
subvariant of SARS-CoV-2 omicron (B. 1.1. 529), known as BA. 4.6, emerged in March …
subvariant of SARS-CoV-2 omicron (B. 1.1. 529), known as BA. 4.6, emerged in March …
[HTML][HTML] Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA. 1/BA. 1.1/BA. 2/BA. 3
M Huang, L Wu, A Zheng, Y Xie, Q He, X Rong, P Han… - Immunity, 2022 - cell.com
SARS-CoV-2 Omicron variant has presented significant challenges to current antibodies
and vaccines. Herein, we systematically compared the efficacy of 50 human monoclonal …
and vaccines. Herein, we systematically compared the efficacy of 50 human monoclonal …
The epidemiological features of the SARS-CoV-2 Omicron subvariant BA. 5 and its evasion of the neutralizing activity of vaccination and prior infection
D Tian, W Nie, Y Sun, Q Ye - Vaccines, 2022 - mdpi.com
From December 2021 to May 2022, the Omicron BA. 1 and BA. 2 subvariants successively
became the most dominant strains in many countries around the world. Subsequently …
became the most dominant strains in many countries around the world. Subsequently …
[HTML][HTML] Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 Omicron BA. 2.86 and FLip variants
Evolution of SARS-CoV-2 requires the reassessment of current vaccine measures. Here, we
characterized BA. 2.86 and the XBB-lineage variant FLip by investigating their neutralization …
characterized BA. 2.86 and the XBB-lineage variant FLip by investigating their neutralization …
BA. 2 and BA. 5 omicron differ immunologically from both BA. 1 omicron and pre-omicron variants
Several studies have shown that SARS-CoV-2 BA. 1 omicron is an immune escape variant.
Meanwhile, however, omicron BA. 2 and BA. 5 became dominant in many countries and …
Meanwhile, however, omicron BA. 2 and BA. 5 became dominant in many countries and …